Compliance of Animal Bite Patients Managed by Intradermal Route of Antirabies Vaccination

Authors

  • Bhavesh Bariya
  • Kalpita S. Shringarpure
  • Sangita V. Patel
  • V. S. Mazumdar
  • Archana U. Gandhi
  • Keyur M. Brahme

DOI:

https://doi.org/10.37591/rrjoi.v3i1.1171

Abstract

Rabies is one of the oldest recognized diseases affecting humans and one of the most important zoonotic diseases in India. Intradermal ARV has been started in the tertiary hospital where this study was done from December 2010. To know the compliance of animal bite patients managed by intra-dermal route of ARV and the reasons for delay or missing the scheduled dosage of ARV, a prospective study was conducted enrolling 250 patients coming to the ARV clinic. The patients who missed the scheduled dosage of ARV and never returned to the ARV clinic were followed through the telephone and their responses for delay or missing the scheduled dosage were recorded and also to know whether the patients had received the scheduled dosage of ARV at any other ARV clinic and thereby rightly classifying the patients as completely or incompletely immunized. Compliance was seen in 70% of the patients, while 30% of them were non-compliant. Holiday being scheduled on the day of ARV dose (40) personal or official workload (33 patients), patient’s forgetfullness about the scheduled date of vaccination (31) were some of the main reasons for not coming regularly to the ARV clinic to receive next scheduled dosage of ARV. It is concluded that counselling about the importance of completion of ARV schedule is of utmost importance. Counselling regarding side effects of ARV may improve compliance among patients by preventing default due to side effect.

 

Keywords: Rabies, intradermal, purified chick embryo cell vaccine

Downloads

Published

2019-04-02

Issue

Vol. 3 No. 1 (2013)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.